Cancer Liver Clinical Trials

2 recruiting

Cancer Liver Trials at a Glance

13 actively recruiting trials for cancer liver are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in New York, Wuhan, and Chicago. Lead sponsors running cancer liver studies include Tongji Hospital, Fudan University, and City of Hope Medical Center.

Browse cancer liver trials by phase

Treatments under study

About Cancer Liver Clinical Trials

Looking for clinical trials for Cancer Liver? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer Liver trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer Liver clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2

AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)

Colorectal Cancer Liver Metastases (CRLM)
Fudan University73 enrolled1 locationNCT07544784
Recruiting
Not Applicable

Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery

Cancer Liver
Cairo University90 enrolled1 locationNCT06621472
Recruiting

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Colon CancerLiver Metastasis Colon CancerAdenocarcinoma of the Rectum+2 more
Memorial Sloan Kettering Cancer Center80 enrolled1 locationNCT04668872
Recruiting

AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)

Colorectal Cancer Liver Metastases (CRLM)
Tongji Hospital1,500 enrolled1 locationNCT07399236
Recruiting

Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection

Colorectal Cancer MetastaticLiver Transplant SurgeryColon Cancer Liver Metastases
Northwestern University80 enrolled1 locationNCT06698146
Recruiting

Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer

Colorectal Cancer Liver Metastasis
Tongji Hospital160 enrolled1 locationNCT07392567
Recruiting

Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases

Metastatic Colorectal Carcinoma (mCRC)Colorectal Cancer Liver Metastases (CRLM)
City of Hope Medical Center500 enrolled1 locationNCT07224724
Recruiting
Phase 2

FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis

Colon Cancer Liver Metastases
Hua Jiang30 enrolled1 locationNCT06801665
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

CancerCancer, BreastCarcinoma+19 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting
Not Applicable

The DRAGON 2 Trial

Colorectal Cancer Liver Metastases (CRLM)Small Future Liver Remnant (FLR)
Maastricht University348 enrolled24 locationsNCT05428735
Recruiting
Phase 2

A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM

Colorectal Cancer Liver Metastasis
Shanghai 6th People's Hospital20 enrolled1 locationNCT06590259
Recruiting
Phase 3

Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases

RegorafenibColorectal Cancer Liver Metastases
Sun Yat-sen University126 enrolled1 locationNCT05794971
Recruiting

Circulating Tumour DNA as a Sensitive and Specific Marker of Response to Therapy and of Occult Disease in Colorectal Cancer

Patients with resectable colorectal cancer liver metastases
Ludwig Institute for Cancer Research100 enrolled1 locationACTRN12612000345886